1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Rescinded offers

Discussion in 'Braeburn Pharmaceuticals' started by anonymous, Dec 30, 2018 at 11:08 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I know the rep in my geography. The person quit.
     

  2. anonymous

    anonymous Guest

    Manager seen at a medical symposium in a different therapeutic area where there is no reason to be there because there is no indication!! #offlabelselling
     
  3. anonymous

    anonymous Guest

    " This medication could help end the Opioid crisis."... Thank you, Captain Obvious. Now just get your product approved and stop making yourself look like a total idiot on LinkedIn. And hire more of your friends and Yes Men and Women. It's a wildly successful model - You're living proof.
     
  4. anonymous

    anonymous Guest

    So can the other 3 already approved drugs just like it genius Mike!
     
  5. anonymous

    anonymous Guest

    guess all the reps can go out and get citizen petitions signed, what a pathetic company.
     
  6. anonymous

    anonymous Guest

    can MT give everyone a break, you don't need to post or like something on L.inkedIn every 15 minutes. We all know that you are a national thought leader on OUD and have so much to say.:rolleyes: